Format

Send to

Choose Destination
Brachytherapy. 2017 Jan - Feb;16(1):59-67. doi: 10.1016/j.brachy.2016.06.003.

The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer.

Author information

1
Tacoma Valley Radiation Oncology Centers, Tacoma, WA, USA. Electronic address: njamiolkowski@acr.org.
2
Department of Radiation Oncology, Brigham and Women's Hospital, Lebanon, NH, USA; Dana Farber/Brigham & Women's Cancer Centers, Weymouth, MA, USA.
3
Schliffer Cancer Center, Wheeling Hospital Medical Park, Wheeling, WV, USA.
4
Department of Radiation Oncology, Bon Secours Cancer Institute, Norfolk, VA, USA.
5
Dartmouth-Hitchcock Medical Center.
6
Roseville Radiation Oncology, Sutter Radiation Oncology Center, Roseville, CA, USA.

Abstract

Transperineal permanent brachytherapy is a safe and effective treatment option for patients with organ-confined prostate cancer. Careful adherence to established brachytherapy standards has been shown to improve the likelihood of procedural success and reduce the incidence of treatment-related morbidity. A collaborative effort of the American College of Radiology (ACR) and the American Brachytherapy Society (ABS) has produced practice parameters for LDR prostate brachytherapy. These practice parameters define the qualifications and responsibilities of all the involved personnel, including the radiation oncologist, physicist and dosimetrist. Factors with respect to patient selection and appropriate use of supplemental treatment modalities such as external beam radiation and androgen suppression therapy are discussed. Logistics with respect to the brachytherapy implant procedure, the importance of dosimetric guidelines, and attention to radiation safety procedures and documentation are presented. Adherence to these parameters can be part of ensuring quality and safety in a successful prostate brachytherapy program.

KEYWORDS:

Brachytherapy; Dosimetry; Prostate cancer; Quality assurance; Safety

PMID:
28109632
DOI:
10.1016/j.brachy.2016.06.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center